AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 278: G710-G717, 2000;
0193-1857/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuemmerle, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuemmerle, J. F.
Vol. 278, Issue 5, G710-G717, May 2000

Endogenous IGF-I regulates IGF binding protein production in human intestinal smooth muscle cells

John F. Kuemmerle

Departments of Medicine and Physiology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia 23298-0711

Human intestinal smooth muscle in culture produces insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3, IGFBP-4, and IGFBP-5, which modulate the effects of IGF-I. This study examined the regulation of IGFBP production by endogenous IGF-I. R3-IGF-I, an agonist unaffected by IGFBPs, elicited concentration-dependent increase in growth, measured by [3H]thymidine incorporation, and production of IGFBP-3, IGFBP-4, and IGFBP-5, measured by Western blot. Antagonists of the IGF-I receptor, IGF-I Analog or monoclonal antibody 1H7, elicited concentration-dependent inhibition of growth and decrease in IGFBP-3, IGFBP-4, and IGFBP-5 production, implying that endogenous IGF-I stimulated growth and IGFBP production. R3-IGF-I-induced increase in IGFBP-3, IGFBP-4, and IGFBP-5 production was partially inhibited by a mitogen-activated protein (MAP) kinase or a phosphatidylinositol-3-kinase (PI 3-kinase) inhibitor and abolished by the combination. We conclude that endogenous IGF-I stimulates growth and IGFBP-3, IGFBP-4, and IGFBP-5 production in human intestinal smooth muscle cells. Regulation of IGFBP production by IGF-I is mediated by activation of distinct MAP kinase and PI 3-kinase pathways, the same pathways through which IGF-I stimulates growth.

mitogen-activated protein kinase; mitogen-activated protein kinase kinase; phosphatidylinositol 3-kinase; cell culture


This article has been cited by other articles:


Home page
JPEN J Parenter Enteral NutrHome page
P. M. Pereira-Fantini, S. L. Thomas, R. G. Taylor, E. Nagy, M. Sourial, P. J. Fuller, and J. E. Bines
Colostrum Supplementation Restores Insulin-like Growth Factor -1 Levels and Alters Muscle Morphology Following Massive Small Bowel Resection
JPEN J Parenter Enteral Nutr, May 1, 2008; 32(3): 266 - 275.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J. M Fleming, J. A Brandimarto, and W. S Cohick
The mitogen-activated protein kinase pathway tonically inhibits both basal and IGF-I-stimulated IGF-binding protein-5 production in mammary epithelial cells
J. Endocrinol., August 1, 2007; 194(2): 349 - 359.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle
Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3{beta} activity
Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G101 - G110.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle, K. S. Murthy, and J. G. Bowers
IGFBP-3 activates TGF-{beta} receptors and directly inhibits growth in human intestinal smooth muscle cells
Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G795 - G802.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
X. Xin, Y. T. Hou, L. Li, P. Schmiedlin-Ren, G. M. Christman, H.-L. Cheng, K. N. Bitar, and E. M. Zimmermann
IGF-I increases IGFBP-5 and collagen {alpha}1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells
Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G777 - G783.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle
IGF-I elicits growth of human intestinal smooth muscle cells by activation of PI3K, PDK-1, and p70S6 kinase
Am J Physiol Gastrointest Liver Physiol, March 1, 2003; 284(3): G411 - G422.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. M. Zimmermann, L. Li, Y. T. Hou, N. K. Mohapatra, and J. B. Pucilowska
Insulin-like growth factor I and insulin-like growth factor binding protein 5 in Crohn's disease
Am J Physiol Gastrointest Liver Physiol, May 1, 2001; 280(5): G1022 - G1029.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle and B. Teng
Regulation of IGFBP-4 levels in human intestinal muscle by an IGF-I-activated, confluence-dependent protease
Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G975 - G982.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. F. Kuemmerle and K. S. Murthy
Coupling of the Insulin-like Growth Factor-I Receptor Tyrosine Kinase to Gi2 in Human Intestinal Smooth Muscle. Gbeta gamma -DEPENDENT MITOGEN-ACTIVATED PROTEIN KINASE ACTIVATION AND GROWTH
J. Biol. Chem., March 2, 2001; 276(10): 7187 - 7194.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online